Smith; Garrick Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Smith; Garrick Paul.The latest application filed is for "phenyl-piperazine derivatives as serotonin reuptake inhibitors".

Company Profile

1.10.8

Smith; Garrick Paul - Valby DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20210276966 - Ruhland; Thomas ; et al.	2021-09-09
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 10,844,029 - Ruhland , et al. November 24, 2	2020-11-24
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20180127389 - Ruhland; Thomas ; et al.	2018-05-10
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 9,708,280 - Ruhland , et al. July 18, 2	2017-07-18
Aminopyridine derived compounds as LRRK2 inhibitors Grant 9,393,248 - Mikkelsen , et al. July 19, 2	2016-07-19
Aminopyridine Derived Compounds as LRRK2 Inhibitors App 20160184317 - Mikkelsen; Gitte Kobberoe ; et al.	2016-06-30
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20160137620 - Ruhland; Thomas ; et al.	2016-05-19
Aminopyridine derived compounds as LRRK2 inhibitors Grant 9,321,748 - Mikkelsen , et al. April 26, 2	2016-04-26
Aminopyridine derived compounds as LRRK2 inhibitors App 20150336942 - Mikkelsen; Gitte Kobberoe ; et al.	2015-11-26
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 8,110,567 - Ruhland , et al. February 7, 2	2012-02-07
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,683,053 - Ruhland , et al. March 23, 2	2010-03-23
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,144,884 - Ruhland , et al. December 5, 2	2006-12-05
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,138,407 - Ruhland , et al. November 21, 2	2006-11-21
Indole Derivatives useful for the treatment of CNS disorders Grant 6,743,809 - Felding , et al. June 1, 2	2004-06-01
Indole and 2,3-dihydroindole derivatives, their preparation and use Grant 6,727,263 - Moltzen , et al. April 27, 2	2004-04-27
Novel compounds and their use as glycine transport inhibitors App 20030181445 - Moltzen, Ejner Knud ; et al.	2003-09-25
Indole derivatives useful for the treatment of CNS disorders App 20030166664 - Felding, Jakob ; et al.	2003-09-04
Indole and 2,3-dihydroindole derivatives, their preparation and use App 20030018050 - Moltzen, Ejner Knud ; et al.	2003-01-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.